Editorial Dept. Voz de la Diaspora
The government of the Dominican Republic agreed to purchase 10 million doses of the coronavirus vaccine developed by British biopharmaceutical AstraZeneca in partnership with the University of Oxford at a unit cost of 4 Dollars.
The signing of the agreement was led by the president, Luis Abinader and is part of the efforts to eradicate COVID-19 from the Caribbean country, said the Presidency in a statement.
Dominican authorities plan to invest 40 million dollars in the purchase of vaccines, with a first payment of 8 million dollars contributed by the private sector, According to the official report.
The supply of vaccines will be used for the immunization of 5 millions of people and the application of a second dose to ensure one hundred percent effectiveness.
AstraZeneca estimates that the vaccine will be available from the first quarter of 2021, successful clinical trials involving a number of 50 a thousand people from different countries, including Brazil, South Africa, Japan, Russia, United Kingdom, and the United States.
The President for Central America and the Caribbean of AstraZeneca, Rafael Mendoza said that amid the challenges of the pandemic, the company remains committed to promoting broad and equitable access to its vaccine in Central America and the Caribbean, after recognizing the efforts of the government and the private sector of the Dominican Republic to face the emergency.
To ensure these objectives, the company will also continue to collaborate with different governments and multilateral organizations to ensure that the AZD1222 vaccine reaches the region at cost during the pandemic., added Mendoza.